ASC Stock Overview
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally.
Notes are coming soon
Ascendis Health Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||R0.61|
|52 Week High||R0.88|
|52 Week Low||R0.48|
|1 Month Change||10.91%|
|3 Month Change||-10.29%|
|1 Year Change||-28.24%|
|3 Year Change||-38.38%|
|5 Year Change||-93.90%|
|Change since IPO||-94.50%|
Recent News & Updates
|ASC||ZA Pharmaceuticals||ZA Market|
Return vs Industry: ASC underperformed the ZA Pharmaceuticals industry which returned -22% over the past year.
Return vs Market: ASC underperformed the ZA Market which returned 1.2% over the past year.
|ASC Average Weekly Movement||8.2%|
|Pharmaceuticals Industry Average Movement||4.6%|
|Market Average Movement||5.0%|
|10% most volatile stocks in ZA Market||12.4%|
|10% least volatile stocks in ZA Market||2.9%|
Stable Share Price: ASC is more volatile than 75% of ZA stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: ASC's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of ZA stocks.
About the Company
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical Devices segments. It offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names.
Ascendis Health Limited Fundamentals Summary
|ASC fundamental statistics|
Is ASC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ASC income statement (TTM)|
|Cost of Revenue||R889.40m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.22|
|Net Profit Margin||-48.67%|
How did ASC perform over the long term?See historical performance and comparison